Viking Therapeutics Inc (USD)
VKTX
Overview
Key Information
Legal Documents
Financials
Overview
| Sector | Healthcare |
| Industry | - |
| Day Range | 5.60 | 6.01 |
| 52-Wk Range | - | - |
| Last Close | 5.75 |
| Mkt Cap (m) | 449.08 |
| Dividend yield | - |
| ISIN | US92686J1060 |
| Volume | 629,025.00 |
| Exchange Venue | NAS |
Company Profile
Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.
Key Information
| Price/Earning | - |
| Price/Book | 1.89 |
| Price/Sales | - |
| P/CF | - |
| Rev Growth (3 year avg) | 0.00 |
| EPS Growth (3 year avg) | - |
| Operating Margin % | - |
| Net Margin % | - |
| Return on Equity | -15.15 |
| Debt/Equity | 0.00 |
Documents
Prospectus
| en 02/08/2019 |
Annual Report
| en 31/12/2020 |
Please refer to the below issuer website for further documents.
Financials
Income Statement
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Revenue (m) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income (m) | -12.00 | -13.85 | -19.07 | -26.16 | -32.69 | -42.66 |
| Net Income (m) | -23.40 | -14.73 | -20.58 | -22.06 | -25.78 | -39.50 |
| Basic EPS | -3.68 | -0.90 | -0.79 | -0.38 | -0.36 | -0.54 |
| Avg. Diluted Shares Outstanding (m) | 6.36 | 16.28 | 25.98 | 57.58 | 71.96 | 72.60 |
Balance Sheet
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Current Assets (m) | 15.20 | 13.97 | 21.85 | 302.13 | 283.50 | 256.10 |
| Non Current Assets (m) | 0.24 | 0.56 | 0.27 | 0.18 | 0.76 | 0.40 |
| Total Assets (m) | 15.44 | 14.54 | 22.12 | 302.31 | 284.26 | 256.50 |
| Current Liabilities (m) | 1.98 | 6.48 | 8.66 | 4.55 | 6.78 | 12.13 |
| Total Liabilities (m) | - | - | - | - | - | - |
| Total Equity (m) | 8.72 | 8.04 | 13.46 | 297.75 | 277.12 | 244.34 |
Cash Flows
| USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
| Operating Cash Flows (m) | -8.73 | -11.07 | -14.76 | -18.76 | -24.75 | -21.78 |
| Capital Expenditure (m) | - | - | - | - | - | - |
Figures are quoted in USD unless stated otherwise
0.26 (4.52%)
$
6.01
Last Price
© 2021 MeDirect Bank (Malta) plc. All rights reserved.